• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对人类免疫缺陷病毒1型包膜糖蛋白第三个可变区产生位点特异性中和人单克隆抗体。

Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein.

作者信息

Gorny M K, Xu J Y, Gianakakos V, Karwowska S, Williams C, Sheppard H W, Hanson C V, Zolla-Pazner S

机构信息

Department of Pathology, New York University Medical Center, NY 10016.

出版信息

Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3238-42. doi: 10.1073/pnas.88.8.3238.

DOI:10.1073/pnas.88.8.3238
PMID:2014246
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC51421/
Abstract

Cell lines secreting IgG1 human monoclonal antibodies (mAb) to the envelope glycoprotein, gp120, of human immunodeficiency virus (HIV) have been produced by transformation of peripheral blood cells from HIV-infected individuals and by fusion of transformed cells to a human-mouse heteromyeloma cell line (SHM-D33). Two human mAbs were site-selected by means of a 23-mer synthetic peptide spanning a portion of the third variable domain of gp120 from the MN strain of HIV. The two heterohybridomas produce three times more IgG than do their parent lymphoblastoid cell lines. The specificities of these mAbs have been mapped to sequences near the tip of the disulfide loop of the gp120 third variable domain, Lys-Arg-Ile-His-Ile and His-Ile-Gly-Pro-Gly-Arg, respectively. The mAbs have dissociation constants of 3.7 x 10(-6) M and 8.3 x 10(-7) M, neutralize HIVMN in vitro at nanogram levels, and bear the characteristics of antibodies associated with protective immunity in vivo.

摘要

通过对感染人类免疫缺陷病毒(HIV)个体的外周血细胞进行转化,并将转化后的细胞与一种人 - 鼠异源骨髓瘤细胞系(SHM - D33)融合,已产生了分泌针对HIV包膜糖蛋白gp120的IgG1人单克隆抗体(mAb)的细胞系。借助一段跨越HIV MN株gp120第三个可变结构域部分的23聚体合成肽,对两种人mAb进行了位点选择。这两种异源杂交瘤产生的IgG比其亲本淋巴母细胞系多三倍。这些mAb的特异性已分别定位到gp120第三个可变结构域二硫键环末端附近的序列Lys - Arg - Ile - His - Ile和His - Ile - Gly - Pro - Gly - Arg。这些mAb的解离常数分别为3.7×10⁻⁶ M和8.3×10⁻⁷ M,在纳克水平下可在体外中和HIVMN,并具有与体内保护性免疫相关的抗体特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39bf/51421/1cdff47b833f/pnas01058-0281-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39bf/51421/1cdff47b833f/pnas01058-0281-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39bf/51421/1cdff47b833f/pnas01058-0281-a.jpg

相似文献

1
Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein.针对人类免疫缺陷病毒1型包膜糖蛋白第三个可变区产生位点特异性中和人单克隆抗体。
Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3238-42. doi: 10.1073/pnas.88.8.3238.
2
Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain.用来自gp120第三可变区的合成肽产生的1型人类免疫缺陷病毒特异性单克隆抗体和组特异性多克隆中和抗体。
J Virol. 1992 Mar;66(3):1823-31. doi: 10.1128/JVI.66.3.1823-1831.1992.
3
Synergistic neutralization of human immunodeficiency virus type 1 by a chimpanzee monoclonal antibody against the V2 domain of gp120 in combination with monoclonal antibodies against the V3 loop and the CD4-binding site.针对gp120 V2结构域的黑猩猩单克隆抗体与针对V3环和CD4结合位点的单克隆抗体联合使用对1型人类免疫缺陷病毒的协同中和作用。
J Virol. 1996 Jul;70(7):4466-73. doi: 10.1128/JVI.70.7.4466-4473.1996.
4
Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1.在血清转化为1型人类免疫缺陷病毒期间抗gp120抗体反应的发展。
J Virol. 1994 Aug;68(8):5142-55. doi: 10.1128/JVI.68.8.5142-5155.1994.
5
Increased Epitope Complexity Correlated with Antibody Affinity Maturation and a Novel Binding Mode Revealed by Structures of Rabbit Antibodies against the Third Variable Loop (V3) of HIV-1 gp120.兔抗 HIV-1 gp120 第三可变环(V3)区抗体结构揭示抗原表位复杂度增加与抗体亲和力成熟及新结合模式的相关性。
J Virol. 2018 Mar 14;92(7). doi: 10.1128/JVI.01894-17. Print 2018 Apr 1.
6
Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.对V3构象敏感表位具有特异性的人源单克隆抗体可中和来自不同进化枝的1型人类免疫缺陷病毒原始分离株。
J Virol. 2002 Sep;76(18):9035-45. doi: 10.1128/jvi.76.18.9035-9045.2002.
7
Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.一组人重组Fab片段对gp120的CD4结合位点的识别特性,这些片段在中和1型人类免疫缺陷病毒方面表现出不同的能力。
J Virol. 1994 Aug;68(8):4821-8. doi: 10.1128/JVI.68.8.4821-4828.1994.
8
Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.在人类免疫缺陷病毒1型感染的人类和猿猴-人类免疫缺陷病毒SHIVSF162P3N感染的猕猴中广泛中和抗体的产生及其通过单体gp120进行的定位
J Virol. 2016 Mar 28;90(8):4017-4031. doi: 10.1128/JVI.02898-15. Print 2016 Apr.
9
Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120.1型人类免疫缺陷病毒的原始分离株对针对gp120的单克隆抗体的中和作用具有相对抗性,并且其中和作用无法通过单体gp120的研究预测。
J Virol. 1995 Jan;69(1):101-9. doi: 10.1128/JVI.69.1.101-109.1995.
10
Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120.抗人免疫缺陷病毒2型gp120的中和单克隆抗体。
J Virol. 1995 Jun;69(6):3333-40. doi: 10.1128/JVI.69.6.3333-3340.1995.

引用本文的文献

1
Impact of IgG Isotype on the Induction of Antibody-Dependent Cellular Phagocytosis of HIV by Human Milk Leukocytes.IgG 同种型对人乳白细胞诱导 HIV 抗体依赖细胞吞噬作用的影响。
Front Immunol. 2022 May 3;13:831767. doi: 10.3389/fimmu.2022.831767. eCollection 2022.
2
Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization.HIV-1 V3环冠的不同构象可成为广泛中和作用的靶点。
Nat Commun. 2021 Nov 18;12(1):6705. doi: 10.1038/s41467-021-27075-0.
3
Phage-DMS: A Comprehensive Method for Fine Mapping of Antibody Epitopes.

本文引用的文献

1
Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.利用肽合成技术探测病毒抗原的表位,分辨率可达单个氨基酸水平。
Proc Natl Acad Sci U S A. 1984 Jul;81(13):3998-4002. doi: 10.1073/pnas.81.13.3998.
2
Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay.通过酶联免疫吸附测定法测量抗原-抗体复合物溶液中的真实亲和常数。
J Immunol Methods. 1985 Mar 18;77(2):305-19. doi: 10.1016/0022-1759(85)90044-4.
3
Determination of intrinsic affinity constants of monoclonal antibodies against carcinoembryonic antigen.
噬菌体-DMS:一种用于精细定位抗体表位的综合方法。
iScience. 2020 Sep 29;23(10):101622. doi: 10.1016/j.isci.2020.101622. eCollection 2020 Oct 23.
4
The Envelope-Based Fusion Antigen GP120C14K Forming Hexamer-Like Structures Triggers T Cell and Neutralizing Antibody Responses Against HIV-1.基于信封的融合抗原 GP120C14K 形成六聚体样结构,引发针对 HIV-1 的 T 细胞和中和抗体反应。
Front Immunol. 2019 Dec 4;10:2793. doi: 10.3389/fimmu.2019.02793. eCollection 2019.
5
Conformational Engineering of HIV-1 Env Based on Mutational Tolerance in the CD4 and PG16 Bound States.基于 CD4 和 PG16 结合态突变容忍性的 HIV-1 包膜构象工程。
J Virol. 2019 May 15;93(11). doi: 10.1128/JVI.00219-19. Print 2019 Jun 1.
6
Phagocytosis of a Model Human Immunodeficiency Virus Target by Human Breast Milk Leukocytes Is Predominantly Granulocyte-Driven When Elicited by Specific Antibody.当特定抗体引发时,人乳白细胞对模型人类免疫缺陷病毒靶标的吞噬作用主要由粒细胞驱动。
Breastfeed Med. 2019 Apr;14(3):185-192. doi: 10.1089/bfm.2018.0232. Epub 2019 Mar 13.
7
Optimized protocol for detection of native, full-length HIV-1 envelope on the surface of transfected cells.用于检测转染细胞表面天然全长HIV-1包膜的优化方案。
Health Sci Rep. 2018 Jul 31;1(9):e74. doi: 10.1002/hsr2.74. eCollection 2018 Sep.
8
Primary Human Neutrophils Exhibit a Unique HIV-Directed Antibody-Dependent Phagocytosis Profile.原发性人中性粒细胞表现出独特的 HIV 定向抗体依赖的吞噬作用特征。
J Innate Immun. 2019;11(2):181-190. doi: 10.1159/000494371. Epub 2018 Dec 17.
9
Human IgM monoclonal antibodies block HIV-transmission to immune cells in cervico-vaginal tissues and across polarized epithelial cells in vitro.人免疫球蛋白 M 单克隆抗体可阻断 HIV 在宫颈阴道组织中向免疫细胞的传播,并可阻断体外极化上皮细胞中的传播。
Sci Rep. 2018 Jul 5;8(1):10180. doi: 10.1038/s41598-018-28242-y.
10
Evaluation of the fusion partner cell line SPYMEG for obtaining human monoclonal antibodies against influenza B virus.评估融合伙伴细胞系SPYMEG用于获得抗乙型流感病毒的人单克隆抗体的情况。
J Vet Med Sci. 2018 Jun 29;80(6):1020-1024. doi: 10.1292/jvms.18-0146. Epub 2018 Apr 17.
抗癌胚抗原单克隆抗体内在亲和常数的测定
Mol Immunol. 1987 Jun;24(6):569-76. doi: 10.1016/0161-5890(87)90037-x.
4
Induction of anti-HIV neutralizing antibodies by synthetic peptides.合成肽诱导抗HIV中和抗体
EMBO J. 1986 Nov;5(11):3065-71. doi: 10.1002/j.1460-2075.1986.tb04607.x.
5
A sensitive radioimmunoprecipitation assay for human immunodeficiency virus (HIV).一种用于人类免疫缺陷病毒(HIV)的灵敏放射免疫沉淀测定法。
J Immunol Methods. 1988 Sep 13;112(2):235-41. doi: 10.1016/0022-1759(88)90363-8.
6
Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome.被动免疫对获得性免疫缺陷综合征相关复合征及获得性免疫缺陷综合征患者的影响。
Proc Natl Acad Sci U S A. 1988 Dec;85(23):9234-7. doi: 10.1073/pnas.85.23.9234.
7
Neutralization of HTLV-III/LAV replication by antiserum to thymosin alpha 1.抗胸腺素α1血清对HTLV-III/LAV复制的中和作用。
Science. 1986 May 30;232(4754):1135-7. doi: 10.1126/science.3010464.
8
Generation of human monoclonal antibodies to human immunodeficiency virus.针对人类免疫缺陷病毒的人源单克隆抗体的产生
Proc Natl Acad Sci U S A. 1989 Mar;86(5):1624-8. doi: 10.1073/pnas.86.5.1624.
9
Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.重塑型人单克隆抗体CAMPATH-1H用于非霍奇金淋巴瘤的缓解诱导
Lancet. 1988 Dec 17;2(8625):1394-9. doi: 10.1016/s0140-6736(88)90588-0.
10
Passive immunoneutralization of human immunodeficiency virus in patients with advanced AIDS.晚期艾滋病患者中人类免疫缺陷病毒的被动免疫中和作用
Lancet. 1988 Sep 17;2(8612):647-52. doi: 10.1016/s0140-6736(88)90468-0.